7 completed, 1 recruiting, 1 terminated, 1 unknown. 10 Phase 1, 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 10 | Completed 7, Recruiting 1, Terminated 1, Unknown 1 |
| Phase 2 | 5 | Completed 4, Recruiting 1 |
Follow Rickets, Hypophosphatemic: new trials by email Literature Review of Rickets, Hypophosphatemic trials Research Report on Rickets, Hypophosphatemic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia KK8123 - X-linked Hypophosphatemia | Phase 1 / Phase 2 | Recruiting | Kyowa Kirin Co., Ltd. | 39 | 2024-10-09 | 2026-11-06 |
| Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Burosumab in Patients Less Than 1 Year of Age Burosumab - X-linked Hypophosphatemia (XLH) | Phase 1 / Phase 2 | Completed | Kyowa Kirin Pharmaceutical Development Ltd | 16 | 2020-02-26 | 2024-11-07 |
| A Study of KRN23 in Subjects With X-linked Hypophosphatemic Rickets/Osteomalacia KRN23 - X-linked Hypophosphatemic Rickets/Osteomalacia | Phase 1 | Completed | Kyowa Kirin Co., Ltd. | 15 | 2014-07-01 | 2017-03-03 |
| Cinacalcet for Fibroblast Growth Factor 23 (FGF23)-Mediated Hypophosphatemia (Hypophosphatemic Rickets) Osteomalacia - Osteomalacia | Phase 1 | Terminated | National Institute of Dental and Craniofacial Research (NIDCR) | 1 | 2012-11-16 | 2018-07-05 |
| An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia KRN23 - X-linked Hypophosphatemia | Phase 1 / Phase 2 | Completed | Kyowa Kirin Co., Ltd. | 23 | 2012-02-01 | 2024-06-18 |
| A Repeated Study of KRN23 in Adults With X-Linked Hypophosphatemia KRN23 - X-linked Hypophosphatemia | Phase 1 / Phase 2 | Completed | Kyowa Kirin Co., Ltd. | 29 | 2011-04-01 | 2024-06-18 |
| A Study of KRN23 in X-linked Hypophosphatemia Placebo, KRN23 - X-linked Hypophosphatemia | Phase 1 | Completed | Kyowa Kirin Co., Ltd. | 42 | 2008-12-01 | 2024-06-17 |
| Growth Hormone Treatment in Children With Hypophosphatemic Rickets norditropine simplex - X Linked Hypophosphatemic Rickets | Phase 1 / Phase 2 | Completed | Bicetre Hospital | 19 | 2006-01-01 | 2016-03-28 |
| Effect of Cinacalcet on Parathyroid Hormone Secretion in Children and Adolescents With Hypophosphatemic Rickets Cinacalcet - Hypophosphatemic Rickets, X-Linked Dominant | Phase 1 | Completed | Children's Mercy Hospital Kansas City | 8 | 2005-06-01 | 2021-01-19 |
| Effects of GH on Body Proportions and Final Height in X-Linked Hypophosphatemic Rickets somatropin - Hypophosphatemic Rickets, Growth Disorders | Phase 1 | Unknown | University of Rostock | 2004-08-01 | 2007-05-14 |
Familial Hypophosphatemic Rickets (9) · Osteomalacia (2) · Bone Diseases (1) · Growth Disorders (1) · Hypophosphatemia (1) · Kidney Diseases (1) · Metabolic Diseases (1) · Musculoskeletal Diseases (1) · Oncogenic osteomalacia (1) · Rare Diseases (1)
Avitaminosis (10) · Bone Diseases, Metabolic (10) · Calcium Metabolism Disorders (10) · Deficiency Diseases (10) · Malnutrition (10) · Nutrition Disorders (10) · Nutritional and Metabolic Diseases (10) · Phosphorus Metabolism Disorders (10) · Rickets (10) · Vitamin D Deficiency (10) · Bone Diseases (9) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (9) · Female Urogenital Diseases (9) · Female Urogenital Diseases and Pregnancy Complications (9) · Genetic Diseases, Inborn (9)
burosumab (5) · Cinacalcet (1) · Growth Hormone (1) · Human Growth Hormone (1)
Kyowa Kirin Co., Ltd. (5) · Bicetre Hospital (1) · Children's Mercy Hospital Kansas City (1) · Kyowa Kirin Pharmaceutical Development Ltd (1) · National Institute of Dental and Craniofacial Research (NIDCR) (1) · University of Rostock (1)
United States (6) · Canada (3) · France (2) · Germany (2) · Spain (2) · Austria (1) · Italy (1) · Japan (1) · South Korea (1) · Sweden (1) · United Kingdom (1)
Amy Zhang, PhD (2) · Dieter Haffner, MD (1) · Dirk Schnabel, MD (1) · Hagen Staude (1) · Rachel I Gafni, M.D. (1) · Rachel Levy-Olomucki, MD (1) · Thomas O. Carpenter, M.D. (1)
PMID 25919461, PMID 24569459, PMID 26073451, PMID 28822957, PMID 39151033, PMID 42044650